• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/5

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

5 Cards in this Set

  • Front
  • Back
(Hayes)
Which of the following is not a recognised consideration for the treatment of post thrombolysis intracranial bleeding?
A. Tranexamic acid
B. Prothrombin concentrates ( PCC)
C. Fresh Frozen Plasma
D. Crypoprecipitate
B. Unclear role at this stage.
Definite use of:
1. A
2. and C or D.
(LITFL / Hayes )
Which of the following is incorrect regarding post thrombolysis intracranial bleeding?
A. The dose of Tranexamic acid is 1 Gram over 10 minutes
B. FFP is given as 4 Units
C. If the patient is on platelets, both DDAVP and platelets can be given.
D. The "usual" measures for controlling raised intracranial pressure (ICP) are employed- including elevating the bed head 30 degrees.
B. 2 units
(Hayes / LITFL)
Which of the following is correct regarding post thrombolysis intracranial bleeding?
A. Cryoprecipitate can be administered immediately without ABO compatibility testing.
B. Cryoprecipitate is given as 10 units IV.
C. The prognosis is usually poor.
D. If there are signs of increased ICP, hyperosmolar therapy is given: mannitol 1G / kg IV
A. Cryoprecipitate requires ABO compatibility testing AND thawing over 30 minutes.
(JANG/NELSON)
Which of the following is incorrect regarding the complications of thrombolysis?
A. The fibrin-specific thrombolytics ( tenectaplase / alteplase) differ in their potency and specificity to fibrin.
B. The incidence of intracranial haemorrhage is at a rate of < 1%
C. Life threatening bleeding from thrombolysis requires cautious use of Blood Products.
D. Most complications of thrombolysis are not recognised until after the bolus and infusion have been completed.
C. "Aggressive" use of Blood Products
(Jang/Nelson)
Which of the following is incorrect regarding the use of reversal agents with complications of thrombolysis?
A. The direct plasminogen inhibitors (Tranexamic acid) are analogues of lysine.
B. Tranexamic acid irreversibly binds plasminogen.
C. The action of thrombolytics is usually complete by the time the plasminogen inhibitors are given.
D. There is no evidence that Tranexamic acid results in intravascular clotting.
B. Reversible binds plasminogen